Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against <i>Candida albicans</i>

Luliconazole is a new topical imidazole antifungal drug for the treatment of skin infections. It has low solubility and poor skin penetration which limits its therapeutic applications. In order to improve its therapeutic efficacy, spanlastics nanoformulation was developed and optimized using a combi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nabil A. Alhakamy, Mohammed W. Al-Rabia, Shadab Md, Alaa Sirwi, Selwan Saud Khayat, Sahar Saad AlOtaibi, Raghad Abkar Hakami, Hadeel Al Sadoun, Basmah Medhat Eldakhakhny, Wesam H. Abdulaal, Hibah M. Aldawsari, Shaimaa M. Badr-Eldin, Mahmoud A. Elfaky
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2021-06-01
coleção:	Pharmaceutics
Assuntos:	luliconazole spanlastics particle size <i>Candida albicans</i> infections lesion score
Acesso em linha:	https://www.mdpi.com/1999-4923/13/7/977
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!